Rankings
▼
Calendar
FENC Q4 2021 Earnings — Fennec Pharmaceuticals Inc. Revenue & Financial Results | Market Cap Arena
FENC
Fennec Pharmaceuticals Inc.
$220M
Q4 2021 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$0
-100.0% YoY
Gross Profit
$0
Operating Income
-$4M
Net Income
-$4M
EPS (Diluted)
$-0.17
QoQ Revenue Growth
NaN%
Cash Flow
Operating Cash Flow
-$3M
Free Cash Flow
-$3M
Stock-Based Comp.
$910,000
Balance Sheet
Total Assets
$22M
Total Liabilities
$7M
Stockholders' Equity
$16M
Cash & Equivalents
$21M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$0
$170,000
-100.0%
Gross Profit
$0
$170,000
-100.0%
Operating Income
-$4M
-$3M
-25.3%
Net Income
-$4M
-$3M
-36.3%
← FY 2021
All Quarters
Q1 2022 →